CAC Software vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by Medtronic

AI Verdict

Tool A provides AI-powered analysis of CT scans to quantify coronary artery calcification, aiding in cardiovascular risk assessment. Tool B is an implantable cardiac monitor that uses AI to improve the accuracy of long-term ECG monitoring for detecting arrhythmias. While both leverage AI in cardiology, they address distinct clinical needs related to structural heart disease versus electrical heart activity, respectively.

Choose CAC Software if…

Choose Imbio's CAC Software if you need an automated, AI-powered analysis of coronary artery calcification from existing non-contrast chest CT scans. This tool is ideal for radiologists and cardiologists seeking to quantify calcification, generate Agatston scores, and visualize arterial calcification to enhance cardiovascular risk assessment and guide patient management.

View CAC Software →

Choose Reveal LINQ if…

Choose Medtronic's Reveal LINQ Insertable Cardiac Monitor if your patient requires long-term, continuous heart monitoring for suspected intermittent arrhythmias or unexplained syncope. This implantable device, with its AccuRhythm™ AI algorithms, is best suited for extended monitoring periods to accurately detect infrequent cardiac events and reduce false alerts, thereby improving diagnostic yield over several years.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software Reveal LINQ
Pricing Unknown Contact vendor
Deployment Cloud-based (SaaS), integrates with PACS The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool A offers higher usability for clinicians by seamlessly integrating into existing DICOM workflows and providing automated analysis without requiring patient-side device management or a surgical procedure. Tool B, while beneficial, introduces complexities related to device implantation and patient interaction with monitoring tools.

Clinical Value

Reveal LINQ

While both offer significant value, Tool B's continuous, long-term monitoring with AI-driven false alert reduction directly addresses a critical diagnostic challenge for elusive cardiac arrhythmias. This leads to enhanced diagnostic yield and potentially earlier intervention for conditions like AFib, which can prevent strokes.

Pricing & Value

Reveal LINQ

Although both require direct contact for pricing, Tool B has publicly available cost-effectiveness data demonstrating its significant value in terms of quality-adjusted life years gained relative to its cost. This makes a strong case for its economic benefit in clinical practice, with an incremental cost-effectiveness ratio well below the established willingness-to-pay threshold.

Enterprise Readiness

CAC Software

Tool A provides more versatile deployment options, including Cloud, On-premise, and Partner platforms, which caters to diverse enterprise IT environments and preferences. Its direct integration into existing DICOM workflows also simplifies adoption for radiology and cardiology departments.

Innovation

Reveal LINQ

While both use AI, Tool B's specific application of deep learning AI to reduce false positives in continuous, long-term ECG monitoring from an implantable device is a more distinct and impactful innovation. This directly addresses a major pain point in ICM usage, improving diagnostic utility and clinician efficiency.

Support & Docs

Reveal LINQ

Medtronic, as a large medical device company, demonstrates a more comprehensive and structured support system with separate lines for patient and technical services, broader operating hours, and an extensive online manual library and patient education resources. Imbio also offers support, but Medtronic's resources appear more extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software Reveal LINQ
Product Name CAC Software Reveal LINQ Insertable Cardiac Monitor
Company Imbio Medtronic
Primary Function Automated image post-processing for coronary artery calcification from non-contrast chest CT. Long-term, accurate heart monitoring using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Key AI Feature/Algorithm Deep-learning based analysis for automated image post-processing. AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause).
Output/Data Provided Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images. Continuous, long-term subcutaneous ECG monitoring, enhanced ECG experience for clinical adjudication.
Target Specialties Cardiology, Radiology Cardiology, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring CAC Software and Reveal LINQ.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software is designed for radiologists and cardiologists to quantify coronary artery calcification from non-contrast chest CT scans, aiding in risk assessment for coronary artery disease. Medtronic's Reveal LINQ ICM provides long-term, continuous subcutaneous ECG monitoring for conditions like atrial fibrillation and syncope, targeting cardiologists and pediatricians.
Imbio's CAC Software analyzes existing non-contrast chest CT images, offering a non-invasive post-processing solution. In contrast, Medtronic's Reveal LINQ ICM is an implantable device that continuously monitors ECG data over an extended period, transmitting it remotely.
Imbio's CAC Software uses deep-learning based analysis for automated image post-processing, quantification of calcification, and 3D visualizations. Medtronic's Reveal LINQ ICM incorporates AccuRhythmu2122 AI algorithms to reduce false alerts for conditions like atrial fibrillation and pause, thereby enhancing diagnostic yield.
Imbio's CAC Software integrates directly into existing DICOM viewing workflows, providing automated analysis from standard CT scans. Medtronic's Reveal LINQ ICM is an implantable device that transmits data to a cloud-based platform (CareLinku2122 network) via a patient smartphone app or home communicator, requiring remote monitoring infrastructure.
Imbio's CAC Software outputs include the Agatston score, arterial age, calcified lesion mass and volume, along with 3D visualizations and annotated images. Medtronic's Reveal LINQ ICM provides continuous ECG monitoring data, enhanced by AI for improved accuracy in detecting arrhythmias like atrial fibrillation and syncope.
AI Tool Finder
AI-powered search. Results may not be comprehensive.